Clinical Trials on Esophageal Neoplasms in Australia

Total 4913 results

Galderma R&D

Completed

Intra-individual Comparison of Efficacy and Safety of Metvix® Natural Daylight Photodynamic Therapy Versus Conventional Metvix® Photodynamic Therapy in Subject With Mild Actinic Keratoses (CoMet)

Actinic Keratoses

Australia
Monash University

Recruiting

Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy: Immunoglobulin Stopping or Extension (RATIONALISE)

Hypogammaglobulinemia | Haematological Malignancy

Australia
Immutep Australia Pty. Ltd.

Completed

Phase 1 Study of IMP321 (Eftilagimod Alpha) Adjuvant to Anti-PD-1 Therapy in Unresectable or Metastatic Melanoma (TACTI-mel)

Stage IV Melanoma | Stage III Melanoma

Australia
AstraZeneca

Completed

ASTERIX: Low Dose ASA and Nexium

Gastroesophageal Reflux

Bulgaria, Italy, South Africa, Spain, Hungary, Canada, Hong Kong, Greece, Germany, Australia, United Kingdom
University Hospital Heidelberg
German Cancer Research Center

Recruiting

INFORM2 Study Uses Nivolumab and Entinostat in Children and Adolescents With High-risk Refractory Malignancies (INFORM2 NivEnt)

Solid Tumor | CNS Tumor

France, Germany, Australia, Austria, Sweden, Netherlands, Switzerland
University of Sydney
Austin Health; Peter MacCallum Cancer Centre, Australia; Western Sydney Local... and other collaborators

Recruiting

Radio-opaque Contrast Agents for Liver Cancer Targeting With KIM During Radiation Therapy (ROCK-RT)

Liver Neoplasm

Australia
Elisabethinen Hospital
Medical University Innsbruck

Recruiting

Circulating Tumor DNA as Marker for Response to Antineoplastic Treatment of Metastatic Cancer (FLUIDO) (FLUIDO)

Metastatic Cancer

Austria
Celgene Corporation

Completed

A Multicentre, Single-arm, Open-label Safety Study of Lenalidomide Plus Dexamethasone in Previously Treated Subjects With Multiple Myeloma

Multiple Myeloma

Ireland, Spain, Australia, Austria, United Kingdom
Melanoma Institute Australia

Withdrawn

Intralesional Sclerosant for in Transit and Cutaneous Melanoma Metastases (INTRANS)

Melanoma | In-Transit Metastasis of Cutaneous Melanoma

Australia
Alloplex Biotherapeutics Inc

Active, not recruiting

Study of SUPLEXA in Patients With Metastatic Solid Tumours and Haematologic Malignancies

Oncology

Australia
CStone Pharmaceuticals
Bayer

Completed

A Study of CS1001 in Combination With Regorafenib in Patients With Advanced or Refractory Solid Tumors

Advanced Refractory Solid Tumors

Australia
Havah Therapeutics Pty Ltd
AstraZeneca

Unknown

Androgen Therapy for Breast Cancer Patients With Aromatase Inhibitor Induced Side-Effects (ART2)

Breast Cancer | Arthralgia | Osteoporosis

Australia
Shengke Pharmaceuticals Pty Ltd

Terminated

First-in Human (FIH) Trial of ETH-155008 in Subjects With B-NHL, CLL/SLL and AML

Leukemia | NHL

Australia
Novartis Pharmaceuticals

Terminated

Adjuvant Docetaxel-Zoledronic Acid in High-risk Early Prostate Cancer Following Prostatectomy.

Prostate Cancer

Australia
Ipsen

Terminated

A Study to Collect the Somatuline® Injector Device Preferences of Patients Living With Neuroendocrine Tumor (NET) and Nurses Involved in the Care of Patients With NET

Neuroendocrine Tumors

Australia
Novartis Pharmaceuticals

Terminated

Glivec® Plus m-FOLFOX Avastin® in Advanced Colorectal Cancer

Advanced Colorectal Cancer

Australia
Bionomics Limited
CPR Pharma Services Pty Ltd, Australia

Terminated

A Phase I, Dose Escalation Study of BNC101 in Patients With Metastatic Colorectal Cancer.

Colorectal Cancer

Australia
Aviel Roy-Shapira, M.D.

Completed

Safety and Efficacy the Medigus SRS Endoscopic Stapling System in Gastroesophageal Reflux Disease (GERD)

Gastroesophageal Reflux Disease (GERD)

United States, Austria, Germany, India, Italy
Sir Charles Gairdner Hospital

Completed

Catheter Over Needle vs Catheter Through Needle

Nerve Block | Catheterization

Australia
Universitaire Ziekenhuizen KU Leuven
University of Sydney

Completed

Presentation of First Time Attenders at Lymphedema Clinics

Lymphedema | Breast Neoplasm

Belgium, Australia
Clarity Pharmaceuticals Ltd

Completed

Positron Emission Tomography (PET) Imaging of Participants With Confirmed Prostate Cancer Using 64Cu-SAR-bisPSMA (PROPELLER) (PROPELLER)

Prostatic Neoplasms

Australia
PharmAbcine

Active, not recruiting

TTAC-0001 and Pembrolizumab Phase Ib Combination Trial in Metastatic Triple-negative Breast Cancer

Triple Negative Breast Cancer

Australia
Krankenhaus Barmherzige Schwestern Linz
Medical University of Vienna

Completed

TRICIN: Prospective Study on the Efficacy of Single Topical Trichloroacetic Acid (TCA) 85% in the Treatment of Cervical Intraepithelial Neoplasia (CIN 1/2) (TRICIN)

Cervical Intraepithelial Neoplasia Grade 1 | Cervical Intraepithelial Neoplasia Grade 2

Austria
Zucero Pty Ltd

Completed

Study of the Safety and Tolerability of IV Infused PG545 in Patients With Advanced Solid Tumours

Advanced Solid Tumours

Australia
Genor Biopharma Co., Ltd.

Completed

Clinical Trial of Comparative Study of GB221 Pharmacokinetics

Metastatic Breast Cancer

Australia
Medical University of Vienna
Medical University of Graz; Medical University Innsbruck; Krankenhaus Barmherzige... and other collaborators

Terminated

Topical Imiquimod Versus Conization to Treat Cervical Intraepithelial Neoplasia (ITIC2)

Cervical Intraepithelial Neoplasia

Austria
Medical University of Vienna

Completed

ITIC (Imiquimod Therapy in Cervical Intraepithelial Neoplasia)-Trial (ITIC)

Cervical Intraepithelial Neoplasia

Austria
University of Sydney
National Health and Medical Research Council, Australia; Family Planning Association...

Unknown

The IMAP Study Improving Management of Mildly Abnormal Pap Smears

Cervix Neoplasms

Australia
OncoMed Pharmaceuticals, Inc.
Novotech (Australia) Pty Limited

Completed

A Study of FOLFIRI Plus OMP-21M18 as 1st or 2nd-line Treatment in Subjects With Metastatic Colorectal Cancer

Colorectal Cancer

Australia, New Zealand
Dizal Pharmaceuticals

Not yet recruiting

DZD8586 in Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma

Lymphoma, Non-Hodgkin

Australia
Galderma R&D

Completed

Metvix PDT in Participant With "High Risk" Basal Cell Carcinoma

Basal Cell Carcinoma

Australia
University Health Network, Toronto
Canadian Cancer Trials Group; Young Investigator Award - American Society of... and other collaborators

Completed

Cognitive Function and Fatigue in Colorectal Cancer (CRC) Patients After Chemotherapy

Fatigue | Colorectal Neoplasm | Cognition

Canada, Australia
Melbourne Health
AnHeart Therapeutics Inc.; Walter and Eliza Hall Institute of Medical Research

Active, not recruiting

A Study of AB-218 in Patients With IDH1 Mutated Low Grade Glioma (AB-218-IIT-201)

Glioma

Australia
Ludwig Institute for Cancer Research
National Cancer Institute (NCI)

Completed

Capecitabine and 131I-huA33 in Patients With Metastatic Colorectal Cancer

Colorectal Neoplasms

Australia
Queensland Centre for Gynaecological Cancer

Completed

Telephone Follow-up After Treatment for Endometrial Cancer (TEACUP)

Endometrial Cancer

Australia
Queensland Centre for Gynaecological Cancer
The University of Queensland; Greenslopes Private Hospital; Sullivan and Nicolaides...

Completed

The Effects of the Endocrine System on Endometrial Cancer (Ghrelin)

Endometrial Cancer

Australia
ETOP IBCSG Partners Foundation
Breast International Group

Completed

Anti-PD-1 Monoclonal Antibody in Advanced, Trastuzumab-resistant, HER2-positive Breast Cancer (PANACEA)

Metastatic Breast Cancer

France, Austria, Belgium, Australia, Italy
Trans Tasman Radiation Oncology Group

Completed

Preoperative Radiotherapy and Chemotherapy in Patients With Locally Advanced Rectal Cancer (PROArCT)

Rectal Cancer

Australia
Peter MacCallum Cancer Centre, Australia

Completed

A Single Arm Trial of Oxaliplatin and 5FU With Concurrent Radiation in Patients With Metastatic Rectal Cancer

Rectal Cancer

Australia
Atridia Pty Ltd.

Active, not recruiting

Phase I Study of SHR-2002 + SHR-1316 in Patients With Advanced Malignant Tumors

Advanced Malignant Tumors

Australia
Medical University of Graz

Completed

Computertomography-guided Wire Marking of the Liver

Secondary Malignant Neoplasm of Liver

Austria
NuvOx LLC
The Alfred

Completed

The Effects of NVX-108 as a Radiation Sensitizer in Glioblastoma (GBM)

Glioblastoma Multiforme

Australia
Avid Radiopharmaceuticals

Recruiting

Early Clinical Evaluation of 18F-LY3546117 in Tumor Imaging

Neoplasms | Neoplasms Malignant

Australia
Cabrini Health

Completed

BMA and Dynamic Nomogram for Survival Prediction in Patients With CRC

Colon Cancer | Model Disease

Australia
Australasian Leukaemia and Lymphoma Group
Merck Sharp & Dohme LLC; Novartis Pharmaceuticals

Unknown

Pegylated Interferon Alfa-2b and Nilotinib for Augmentation of Complete Molecular Response in Chronic Myeloid Leukaemia (PInNACLe)

Chronic Myeloid Leukaemia

Australia
Ethicon Endo-Surgery

Active, not recruiting

RETHINK REFLUX Registry

Gastroesophageal Reflux

United States, Singapore, Germany, Austria, Italy, United Kingdom
Ludwig Institute for Cancer Research
Daiichi Sankyo, Inc.

Completed

A Phase I Imaging and Pharmacodynamic Trial of CS-1008 in Patients With Metastatic Colorectal Cancer

Colorectal Neoplasms

Australia
Peter MacCallum Cancer Centre, Australia
Melbourne Health; M.D. Anderson Cancer Center; The Alfred

Completed

Volatile Anaesthesia and Perioperative Outcomes Related to Cancer Feasibility Study (VAPOR-C)

Cancer, Breast | Cancer Colorectal | Cancer, Lung | Cancer Prostate | Cancer Melanoma Skin | Cancer, Other

Australia
Adagene Inc

Recruiting

Study of ADG206 in Subjects With Advanced/Metastatic Solid Tumors

Advanced/Metastatic Solid Tumors

Australia
Imago BioSciences, Inc., a subsidiary of Merck...

Completed

A Study of Bomedemstat (IMG-7289/MK-3543) With and Without ATRA, in Participants With Advanced Myeloid Malignancies (IMG-7289-CTP-101/MK-3543-001)

Acute Myeloid Leukemia | Myelodysplastic Syndrome

Australia

Clinical Trials on Esophageal Neoplasms in Australia

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Rwanda

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations